Itaconate shunt hypothesis
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
The Itaconate Shunt hypothesis for ME/CFS was devised by Dr Robert Phair, PhD, with Professor Ronald Davis at the Open Medicine Foundation. It builds on earlier findings by McGregor et al. (2019).[1][2]
Theory[edit | edit source]
Evidence[edit | edit source]
Treatment[edit | edit source]
Interviews and videos[edit | edit source]
- 2022, Itaconate Shunt Hypothesis for ME/CFS - Rob Phair, PhD
- 2022, Itaconate pathway - Ron Davis
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "Dr Rob Phair presents the Itaconate Shunt Hypothesis for ME/CFS". YouTube. July 12, 2022.
- ↑ McGregor, Neil R.; Armstrong, Christopher W.; Lewis, Donald P.; Gooley, Paul R. (July 4, 2019). "Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases". Diagnostics. 9 (3): 70. doi:10.3390/diagnostics9030070. ISSN 2075-4418.
